ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Unbiased tensor-based morphometry: Improved robustness and sample size estimates for Alzheimer's disease clinical trials

Hua, Xue; Hibar, Derrek P.; Ching, Christopher R. K.; Boyle, Christina P.; Rajagopalan, Priya; Gutman, Boris A.; Leow, Alex D.; Toga, Arthur W.; Jack, Clifford R., Jr.; Harvey, Danielle; Weiner, Michael W.; Thompson, Paul M.*uc davis
NeuroImage2013-2-1DOI: 10.1016/j.neuroimage.2012.10.086
91被引2阅读
引用收藏
分享

摘要

Various neuroimaging measures are being evaluated for tracking Alzheimer's disease (AD) progression in therapeutic trials, including measures of structural brain change based on repeated scanning of patients with magnetic resonance imaging (MRI). Methods to compute brain change must be robust to scan quality. Biases may arise if any scans are thrown out, as this can lead to the true changes being overestimated or underestimated. Here we analyzed the full MRI dataset from the first phase of Alzheimer's Disease Neuroimaging Initiative (ADNI-1) from the first phase of Alzheimer's Disease Neuroimaging Initiative (ADNI-1) and assessed several sources of bias that can arise when tracking brain changes with structural brain imaging methods, as part of a pipeline for tensor-based morphometry (TBM). In all healthy subjects who completed MRI scanning at screening, 6, 12, and 24 months, brain atrophy was essentially linear with no detectable bias in longitudinal measures. In power analyses for clinical trials based on these change measures, only 39 AD patients and 95 mild cognitive impairment (MCI) subjects were needed for a 24-month trial to detect a 25% reduction in the average rate of change using a two-sided test (alpha=0.05, power=80%). Further sample size reductions were achieved by stratifying the data into Apolipoprotein E (ApoE) epsilon 4 carriers versus non-carriers. We show how selective data exclusion affects sample size estimates, motivating an objective comparison of different analysis techniques based on statistical power and robustness. TBM is an unbiased, robust, high-throughput imaging surrogate marker for large, multi-site neuroimaging studies and clinical trials of AD and MCI.

学科与关键词

关键词
Alzheimer's diseaseMild cognitive impairmentAgingADNITensor-based morphometryDrug trial
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
NeuroImage
发表日期
2013-02-01
卷期
第 66 卷
页码
648-661
DOI
10.1016/j.neuroimage.2012.10.086
语言
ENGLISH
期刊等级
Q1
成果收录
SCIE
资助标注
Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; NIA, NIBIB; National Library of Medicine; National Center for Research Resources [AG016570, EB01651, LM05639, RR019771]

作者

  • H

    Hua, Xue (第一作者)

  • H

    Hibar, Derrek P.

查看全部 12 位作者收起作者
  • C

    Ching, Christopher R. K.

  • B

    Boyle, Christina P.

  • R

    Rajagopalan, Priya

  • G

    Gutman, Boris A.

  • L

    Leow, Alex D.

  • T

    Toga, Arthur W.

  • J

    Jack, Clifford R., Jr.

  • H

    Harvey, Danielle

    uc davis

  • W

    Weiner, Michael W.

  • T

    Thompson, Paul M. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417